Report Overview

The South Korea Crohns disease market size stood at around USD xx billion in 2019 and is projected to reach xx billion by 2028, exhibiting a CAGR of around 3.8 % during the forecast period.

Crohn's disease is a type of inflammatory bowel disease (IBD). It causes inflammation of your digestive tract, which can lead to abdominal pain, severe diarrhoea, fatigue, weight loss and malnutrition. Inflammation caused by Crohn's disease can involve different areas of the digestive tract in different people. This inflammation often spreads into the deeper layers of the bowel. Crohn's disease can be both painful and debilitating, and sometimes may lead to life-threatening complications.

While there is no known cure for Crohn's disease, therapies can greatly reduce its signs and symptoms. With treatment, many people with Crohn's disease are able to function well.



Market Drivers

According to the results of an epidemiological survey that tracked the average incidence of inflammatory bowel disease in Korea for 30 years, as of 2015 among 100,000 people, the number of patients with Crohn's disease was 2.42 and it is steadily rising. Furthermore, research on new drugs with new mechanisms for a large number of patients who do not respond to treatment is in progress. These factors will drive the market in forecast period.

Launch of biosimilars is expected to affect the sales of original products, but the impact is limited. The high growth rate of the Crohn's disease market is expected to be maintained despite the launch of these biosimilars and high drug prices.